Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker LMT
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 22, 2026 | LMT Lockheed Martin Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 28, 2026 | LMT Lockheed Martin Corporation | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 23, 2026 | LMT Lockheed Martin Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 13, 2026 | LMT Lockheed Martin Corporation | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 23, 2026 | LMT Lockheed Martin Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 29, 2026 | LMT Lockheed Martin Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 18, 2025 | LMT Lockheed Martin Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 9, 2025 | LMT Lockheed Martin Corporation | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 21, 2025 | LMT Lockheed Martin Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 29, 2025 | LMT Lockheed Martin Corporation | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 28, 2025 | LMT Lockheed Martin Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 22, 2025 | LMT Lockheed Martin Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 9, 2025 | LMT Lockheed Martin Corporation | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 22, 2025 | LMT Lockheed Martin Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 17, 2025 | LMT Lockheed Martin Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 28, 2025 | LMT Lockheed Martin Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 11, 2024 | LMT Lockheed Martin Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 11, 2024 | LMT Lockheed Martin Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 13, 2024 | LMT Lockheed Martin Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
19 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:13 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances